ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,004, issued on Oct. 6, was assigned to IOGENETICS LLC (Madison, Wis.).
"Enhancement of immune response with oral immunoglobulin polypeptides" was invented by Robert D. Bremel (Hillpoint, Wis.) and Jane Homan (Hillpoint, Wis.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a means to prepare a product from domestic animal milk, blood or eggs which comprises an array of T-cell exposed motifs similar in identity, distribution and concentration to those found in human immunoglobulin variable regions and to prepare and apply the product as an immune modulating agent for administration either as a nutritional supplement or as ...